Biologic Exclusivity Provision In USMCA Is Boon To Generics Industry; BIO Is 'Tremendously Worried'

 
• By Brenda Sandburg
  
Washington, DC - January 2019: USMCA United States Mexico Canada Agreement Treaty. Political Contract And Deal By Donald Trump - 2d Illustration
Deal revising the USMCA strips biologics exclusivty provision and other pharma IP requirements
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet